Preliminary Data
Last Update Q1 2022
Valuation | Industry Range | |
---|---|---|
Price / Earnings | N/A | |
Book Value | 1.76 |   |
Earnings Per Share | -$3.20 |   |
Price To Sales Ratio | 65.08 |   |
Price To Book Ratio | 28.54 |   |
Price To Tangible Book Ratio | 28.55 |   |
Price/Cash Flow Ratio | N/A | |
Price/Free Cash Flow Ratio | N/A |
Profile | Industry Range | |
---|---|---|
Market Capitalization | 3.6B |   |
Float (MRQ) | 93.98% |   |
Shares Outstanding (MRQ) | 84.1M |   |
Short Interest as a % of Float (MRQ) | 9.82% |   |
Shares Held By Institutions (MRQ) | 33.5M |   |
Margins | Industry Range | |
---|---|---|
Sales | $70.4M |   |
Gross Margin | 96.18% |   |
Net Profit Margin | -365.84% |   |
EBIT Margin | -317.43% |   |
EBITDA Margin | -193.96% |   |
Operating Margins | -264.54% |   |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
Financial Strength | Industry Range | |
---|---|---|
Current Ratio (MRQ) | 7.45 |   |
Quick Ratio (MRQ) | 7.45 |   |
Total Debt/Equity Ratio (MRQ) | 277.13 |   |
Debt/Common Equity Ratio (MRQ) | 277.13 |   |
Effectiveness | Industry Range | |
---|---|---|
Return on Equity | -178.55% |   |
Return on Assets | -56.38% |   |
Asset Turnover | 0.15 |   |
Receivables Turnover | 5.11 |   |
Inventory Turnover | N/A |
Earnings and Dividends | Industry Range | |
---|---|---|
EPS Growth Annual | 40.80% |   |
Dividend Yield 5 Year Average | 0.00% |   |
Current Dividend Yield | 0.00% |   |
Current Payout Ratio | N/A |
*CYTK does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Major industry is 2.22%